Christopher Cannon Shares A Study Showing No Benefit When Adding an Antiplatelet to Anticoagulant in Stroke with AF and Atherosclerosis
Christopher Cannon, Cardiologist at Brigham and Women’s Hospital, Editor-in-Chief of Harvard Heart Letter, shared on LinkedIn:
”Small randomized trial showing no benefit, and increased bleeding when adding an antiplatelet to anticoagulant in those with stroke , atherosclerosis and AF.”
Read the full article in JAMA Neurology.
Article: Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis. A Randomized Clinical Trial
Authors: Shuhei Okazaki, Kanta Tanaka, Yukako Yazawa, Ryosuke Doijiri, Masatoshi Koga, Masafumi Ihara, Shiro Yamamoto, Kenji Kamiyama, Yuko Honda, Kazutaka Uchida, Takeshi Yoshimoto, Koko Asakura, Katsuhiro Omae, Kenta Tanaka, Hirotada Maeda, Haruko Yamamoto, Teruyuki Hirano, Kazunori Toyoda, Yasuyuki Iguchi, Teruo Noguchi, Yasushi Okada, Kazuo Kitagawa, Nobuyuki Sakai, Hiroshi Yamagami
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Mar 13, 2026, 21:19New Canadian Insights on Switching to Longer-Acting Therapy for Hemophilia A – WFH
-
Mar 13, 2026, 21:01Leonardo Roever: Brain Age as a Biomarker of Neuroplasticity and Motor Recovery After Stroke
-
Mar 13, 2026, 20:50William Tembo: Understanding Stroke Through Landmark Clinical Trials
-
Mar 13, 2026, 20:35Jessica Garcia: New Evidence on Thrombin Generation Patterns in Children with Hemophilia A
-
Mar 13, 2026, 20:11Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
-
Mar 13, 2026, 19:53Wolfgang Miesbach Announces the New English Edition of “Gene Therapy Concepts in the Treatment of Haemophilia”
-
Mar 13, 2026, 17:21Emmanuel J Favaloro: Acquired Hemostasis Disorders Featured in New Issue of Seminars in Thrombosis and Hemostasis
-
Mar 13, 2026, 17:17Paolo Zamboni: New Insights from Australia on Jugular and Azygous Vein Chronic Obstruction
-
Mar 13, 2026, 17:06Srishti Goyal: Can Thalassemia Major Be Prevented?